Home › Leucemia mieloide acuta › Iowa › Cedar Rapids
Studi clinici su Leucemia mieloide acuta a Cedar Rapids, IA
16 studi su Leucemia mieloide acuta cercano partecipanti presso sedi a Cedar Rapids e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
In reclutamentoFase 2
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · a 25 mi di distanza
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
In reclutamentoFase 2
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · a 25 mi di distanza
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
In reclutamentoFase 2
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · a 25 mi di distanza
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
In reclutamentoFase 2
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · a 25 mi di distanza
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
In reclutamentoFase 3
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · a 25 mi di distanza
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
In reclutamentoFase 1/2
- University of Iowa Hospital, Iowa City · a 25 mi di distanza
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
In reclutamentoStudio osservazionale
- University of Iowa Hospital and Clinics, Iowa City · a 25 mi di distanza
High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML)
In reclutamentoFase 1
- University of Iowa Health Care, Iowa City · a 25 mi di distanza
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
In reclutamentoFase 1/2
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · a 25 mi di distanza
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
In reclutamentoFase 3
- University of Iowa Stead Family Children's Hospital, Iowa City · a 25 mi di distanza
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
In reclutamentoFase 3
- University of Iowa, Iowa City · a 25 mi di distanza
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
In reclutamentoFase 1
- University of Iowa Hospitals & Clinics, Iowa City · a 25 mi di distanza
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
In reclutamentoFase 3
- University of Iowa Hospitals and Clinics, Iowa City · a 25 mi di distanza
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
In reclutamentoStudio osservazionale
- University of Iowa, Iowa City · a 25 mi di distanza
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
In reclutamentoFase 1
- University of Iowa Hospitals & Clinics, Iowa City · a 25 mi di distanza
Studi su Leucemia mieloide acuta in altre città
- Houston, TX85 studi
- New York City, NY51 studi
- Boston, MA44 studi
- Baldwin Park, CA40 studi
- Seattle, WA40 studi
- Columbus, OH35 studi
- Philadelphia, PA34 studi
- Durham, NC33 studi
- Atlanta, GA30 studi
- Tampa, FL29 studi
- Chicago, IL26 studi
- Portland, OR25 studi
Altri studi a Cedar Rapids
- Cancro del polmone non a piccole cellule20 studi
- Cancro al seno17 studi
- Cancro (tutti i tipi)15 studi
- Mieloma multiplo15 studi
- Cancro ai polmoni14 studi
- Cancro colorettale13 studi
- Cancro alla prostata12 studi
- Carcinoma a cellule squamose della testa e del collo12 studi
- Melanoma10 studi
- Ictus10 studi
- Cancro metastatico9 studi
- Cancro dell'endometrio9 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.